Group 1 - The report indicates that Huaron Chemical Co., Ltd. has effectively established and implemented various internal regulations to prevent related party transactions and manage fundraising [1][2] - The company has not missed any deadlines for reviewing information disclosure documents, with zero instances of late reviews [1] - There have been no reported issues requiring attention, and the company has maintained compliance with regulatory requirements [2] Group 2 - All major contracts have been executed normally without any significant risks affecting their performance during the reporting period [2] - The sponsor has not faced any regulatory actions from the China Securities Regulatory Commission or the Shenzhen Stock Exchange during the reporting period [2]
华融化学: 华泰联合证券关于华融化学股份有限公司2025年上半年度持续督导跟踪报告